Search Results - "Bomback, A S"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Low-dose spironolactone, added to long-term ACE inhibitor therapy, reduces blood pressure and urinary albumin excretion in obese patients with hypertensive target organ damage by Bomback, A S, Muskala, P, Bald, E, Chwatko, G, Nowicki, M

    Published in Clinical nephrology (01-12-2009)
    “…For some hypertensive patients, conventional blockade of the renin-angiotensin-aldosterone system with angiotensin-converting enzyme (ACE) inhibitors or…”
    Get more information
    Journal Article
  2. 2

    Definition, identification and treatment of resistant hypertension in chronic kidney disease patients by Drexler, Yelena R, Bomback, Andrew S

    Published in Nephrology, dialysis, transplantation (01-07-2014)
    “…Resistant hypertension, the inability to achieve goal blood pressure despite the use of three or more appropriately dosed antihypertensive drugs (including a…”
    Get full text
    Journal Article
  3. 3

    Dual Blockade of the Renin–Angiotensin–Aldosterone System: Beyond the ACE Inhibitor and Angiotensin-II Receptor Blocker Combination by Bomback, Andrew S., Toto, Robert

    Published in American journal of hypertension (01-10-2009)
    “…The renin–angiotensin–aldosterone system (RAAS), an important regulator of blood pressure as well as fluid and electrolyte balance, plays an important role in…”
    Get full text
    Journal Article
  4. 4

    Rituximab treatment for fibrillary glomerulonephritis by Hogan, Jonathan, Restivo, Michaela, Canetta, Pietro A, Herlitz, Leal C, Radhakrishnan, Jai, Appel, Gerald B, Bomback, Andrew S

    Published in Nephrology, dialysis, transplantation (01-10-2014)
    “…Approximately 50% of patients with fibrillary glomerulonephritis (GN) progress to end-stage renal disease (ESRD) within 2 years of diagnosis, and no standard…”
    Get full text
    Journal Article
  5. 5

    Renal-limited 'lupus-like' nephritis by HUERTA, Ana, BOMBACK, Andrew S, LIAKOPOULOS, Vassilis, PALANISAMY, Amudha, BARRY STOKES, M, D'AGATI, Vivette D, RADHAKRISHNAN, Jai, MARKOWITZ, Glen S, APPEL, Gerald B

    Published in Nephrology, dialysis, transplantation (01-06-2012)
    “…In the setting of an IgG-dominant immune complex-mediated glomerulonephritis, there are multiple pathological findings that strongly suggest the diagnosis of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy by Bomback, Andrew S., Song, Huijuan, D'Agati, Vivette D., Cohen, Scott D., Neal, Alison, Appel, Gerald B., Rovin, Brad H.

    Published in Nephrology, dialysis, transplantation (01-10-2010)
    “…Lipoprotein glomerulopathy is a rare disease diagnosed by unique histopathologic findings of glomerular capillary dilatation by lipoprotein thrombi. The…”
    Get full text
    Journal Article
  8. 8

    Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience by Bang, Heejung, Mazumdar, Madhu, Newman, George, Bomback, Andrew S., Ballantyne, Christie M., Jaffe, Allan S., August, Phyllis A., Kshirsagar, Abhijit V.

    Published in Nephrology, dialysis, transplantation (01-08-2009)
    “…Background. SCreening for Occult REnal Disease (SCORED) is a novel screening guideline recently developed to identify individuals with a high likelihood of…”
    Get full text
    Journal Article
  9. 9
  10. 10